How Radiopharmaceuticals Help Diagnose Cancer and Cardiovascular Disease

Producer:
Video: Martin Klingenboeck, Story: Alejandra Silva, Additional Footage: Pablo Massip Ginesta

Technetium-99m is the most widely used radioisotope in diagnostic nuclear medicine. Over 10,000 hospitals worldwide use it to detect cancer, cardiovascular and other chronic diseases, so that they can be treated.

Related Resources

More

Department of Nuclear Sciences and Applications Division of Physical and Chemical Sciences Radioisotope Products and Radiation Technology Section Division of Human Health Nuclear Medicine and Diagnostic Imaging Section Cardiovascular diseases Cancer diagnosis Diagnostics Diagnostic radiopharmaceuticals Health Cancer

More on the IAEA

  1. Contact
  2. Privacy Policy
  3. Logo Usage Guidelines

Scientific resources

  1. NUCLEUS
  2. International Nuclear Information System (INIS)
  3. Power Reactor Information System (PRIS)
  4. Nuclear Data Services (NDS)

Resources

  1. Employment
  2. Gender at the IAEA
  3. Press

Documents

  1. Information Circulars
  2. Treaties
  3. Standards and guides
  4. Safeguards and Additional Protocol

Stay in Touch